AXL –GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases
ConclusionsAXL –GAS6 co-expression represents a potential independent prognostic biomarker for survival outcome in NSCLC BM patients.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Pathology | Smokers | Study